article thumbnail

World’s Top 10 Pharma Companies (By 2023 Revenue)

XTalks

The top ten pharma companies in 2023 by revenue accounted for about 35 percent of the market value, with total earnings of $559.5 The top big pharma players have remained relatively consistent in their market positions over the past several years. Here is a look at the top ten pharma companies in 2024 based on 2023 revenue.

article thumbnail

What are the Vital Advantages Offered by PCD Pharma Companies?

Fossil Remedies

There are many types of pharma businesses and one can choose any of them. Launching a pcd pharma company, for example, can be a way of reaping the benefit of pharma boom. If you are running a small business in this niche, then it is time for you to invest in any of the good pharma companies. Conclusion.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ipsen plans sale of consumer health business for €350m

pharmaphorum

Ipsen has started exclusive negotiations that could see its global consumer health business sold to fellow French pharma company Mayoly Spindler later this year. billion takeover of Clementia Pharma in 2019. The post Ipsen plans sale of consumer health business for €350m appeared first on.

Sales 94
article thumbnail

Industry rejects ‘damaging’ changes to UK medicines scheme

Drug Discovery World

Over twenty pharma companies have rejected the UK government’s proposed changes to the statutory scheme for branded medicines, the latest move in an ongoing disagreement between the government and industry. And will be “highly damaging to UK life sciences and NHS patients’ access to medicines”.

article thumbnail

Merck sees big lift in Keytruda sales, as Senate probes its taxes

pharmaphorum

Merck & Co has reported record sales of its cancer immunotherapy Keytruda in the second quarter, as members of the Senate Finance Committee continue an investigation into the way the company books profits from the drug. billion from sales of its COVID-19 antiviral Lagevrio (molnupiravir) in the second quarter, down from $3.2

Sales 57
article thumbnail

Jazz Pharma Announces $100 Million “Green” Manufacturing Plant for Cannabis-Based Medicines

XTalks

Jazz Pharmaceuticals has broken ground on a new $100 million manufacturing plant for cannabis-based medicines in the UK. According to a press release from Jazz Pharma, the plant has a planned opening date in 2024 and will welcome 100 new employees. The net product sales of Epidiolex were $463.6 million in 2021, or $658.3

Medicine 111
article thumbnail

Teva says medicines access at risk in Northern Ireland

pharmaphorum

The North Ireland Protocol has been a source of tension between the UK and EU since it came into force at the start of 2021 – and according to one pharma company the end of the so-called ‘grace period’ could result in major issues with medicines supply.

Medicine 104